Garlic constituent diallyl trisulfide induced apoptosis in MCF7 human breast cancer cells

Cancer Biology and Therapy

Volumn 8, Issue 22, 2009, Pages 2174-2184

  Malki, Ahmed ^a,b   El Saadani, Muhammad ^a,b   Sultan, Ahmed S ^a,c  

^a Alexandria University Faculty Of Science   (Egypt)

^b GENETIC ENGINEERING AND BIOTECHNOLOGY RESEARCH INSTITUTE   (Egypt)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

Akt; Apoptosis; Bax; Breast cancer; Cell cycle; DATS; p53

Indexed keywords

EID: 84862728631     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.8.22.9882     Document Type: Article

References (72)

1. Smigal C, Jemal A, Ward E, Cokkinides V, Smith R, Howe H, et al. Trends in breast cancer by race and ethnicity: Update. CA Cancer J Clin 2006; 56:106-30.
2. Russo J, Yang X, Hu Y. Biological and molecular basis of human breast cancer. Frontiers Biosci 1998; 3:944-60.
3. Nathanson KL, Wooster R, Weber BL. Breast cancer genetics. What we know and what we need. Nat Med 2001; 7:552-6. (Pubitemid 32448321)
4. You WC, Blot WJ, Chang YS. Allium vegetables and reduced risk of stomach cancer. J Natl Cancer Inst 1989; 18:162-4. (Pubitemid 19031335)
5. Brenda K, Martin L, Phyllis A. Annual Report to the nation on the status of cancer. 1975-2002 featuring population-based trend in cancer treatment. J Natl Cancer Inst 2005; 97:1407-27.
6. Simstein R, Burow M, Parker A. Apoptosis, chemoresistance and breast cancer: Insights from the MCF-7 cell model system. Exp Biol Med 2003; 228:995-1003. (Pubitemid 37222167)
7. Wu J. Apoptosis and angiogenesis: two promising tumor markers in breast cancer (review). Anticancer Res 1996; 16:2233-40.
8. Furth PA. Apoptosis and the development of breast cancer. Bowcock AM, Ed. Breast Cancer: Molecular Genetics, Pathogenesis and Therapeutics. New Jersey: Humana Press 1999; 171-80.
9. Debatin AK. Activation of apoptosis pathways by anticancer treatment. Toxicol Lett 2000; 112:41-8.
10. Shao ZM, Li J, Wu J, Han QX, Shen ZZ, Fontana JA, et al. Neo-adjuvant chemotherapy for operable breast cancer induces apoptosis. Br J Cancer Res Treat 1999; 53:263-9. (Pubitemid 29209895)
11. Xiao D, Singh SV. Diallyl trisulfide, a constituent of processed garlic, inactivates Akt to trigger mitochondrial translocation of BAD and caspase-mediated apoptosis in human prostate cancer cells. Carcinogenesis 2006; 27:533-40. (Pubitemid 43372883)
12. Antosiewicz J, Herman-Antosiewicz A, Marynowski SW, Singh SV. c-Jun NH2-terminal kinase signaling axis regulates diallyl trisulfide-induced generation of reactive oxygen species and cell cycle arrest in human prostate cancer cells. Cancer Res 2006; 66:5379-86. (Pubitemid 43844964)
13. Sundaram SG, Milner JA. Diallyl disulfide induces apoptosis of human colon tumor cells. Carcinogenesis 1996; 17:669-73. (Pubitemid 26129678)
14. Knowles LM, Milner JA. Diallyl disulfide inhibits p34 (cdc2) kinase activity though changes in complex formation and phosphorylation. Carcinogenesis 2000; 21:1129-34. (Pubitemid 30389337)
15. Dorant E. Garlic and its significance for the prevention of cancer in humans: A critical view. Br J Cancer 1993; 67:424-9. (Pubitemid 23077632)
16. Wargovich MJ. Diallyl sulfide, a flavor component of garlic (Allium sativum), inhibits dimethyihydrazine-induced colon cancer. Carcinogenesis 1987; 8:487-9. (Pubitemid 17126191)
17. Reddy BS, Rao CV, Rivenson A, Kelloff G. Chemoprevention of colon carcinogenesis by organosulfur compounds. Cancer Res 1993; 53:3493-8. (Pubitemid 23229625)
18. Sundaram SG, Milner JA. Diallyl disulfide present in garlic oil inhibits both in vitro and in vivo growth of human colon tumor cells. FASEB J 1995; 9:869-73.
19. Sundaram SG, Milner JA. Organosulfur compounds in processed garlic alter the in vitro growth of human tumor cell lines. FASEB Journal 1994; 8:426-30.
20. Knowles LM, Miller JA. Garlic constituents alter cell cycle progression and proliferation. FASEB J 1997; 11:422-8.
21. Knowles LM, Milner JA. Diallyl disulfide increases cyclin B1 protein expression and depresses phosphatase activity in HCT-15 cells. FASEB J 1998; 12:656.
22. Hawkins DS, Demers GW, Galloway DA. Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents. Cancer Res 1996; 56:892-8. (Pubitemid 26055483)
23. Wahl AF, Donaldson KL, Fairchild C, Lee FYF, Foster SA, Demers GW, et al. Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis. Nat Med 1996; 2:72-9. (Pubitemid 26029571)
24. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75:817-25. (Pubitemid 23346378)
25. Malki A, Pulipaka A, Evans S, Bergmeier S. Structure-activity studies of quinoclidinone analogs as antiproliferative agents in lung cancer cell lines. Bioorg Med Chem Lett 2006; 16:1156-9. (Pubitemid 43142982)
26. Adachi H, Preston G, Harvat B. Inhibition of cell proliferation and induction of apoptosis by the retinoid AHPN in human lung carcinoma cells. Am J Respir Cell Mol Biol 1998; 18:323-7.
27. Cory S, Adams JM. The Bcl2 family: regulators of the cellular life or death switch. Nat Rev Cancer 2002; 2:647-56. (Pubitemid 37328916)
28. Nagata S, Golstein P. The Fas death factor. Science 1995; 267:1449-52.
29. McPherson K, Steel CM, Dixon JM. ABC of breast diseases. Breast cancer-epidemiology, risk factors and genetics. BMJ 2000; 321:624-8.
30. Chang S, Parker SL, Pham T, Buzdar AU, Hursting SD. Inflammatory breast carcinoma incidence and survival-the surveillance, epidemiology and end results program of the national cancer institute, 1975-1992 Breast Can Res Treat 1997; 46:40-7.
31. You WC, Blot WJ, Chang YS, Ershow A, Yang ZT, An Q, et al. Allium vegetables and reduced risk of stomach cancer. J Natl Cancer Inst 1989; 18:162-4. (Pubitemid 19031335)
32. Challier B, Perarnau JM, Viel JF. Garlic, onion and cereal fibre as protective factors for breast cancer: a French case-control study. Eur J Epidemiol 1998; 14:737-47. (Pubitemid 29038333)
33. Gao CM, Takezaki T, Ding JH. Protective effect of allium vegetables against both esophageal and stomach cancer: a simultaneous case-referent study of a high-epidemic area in Jiangsu Province, China. Jpn J Cancer Res 1999; 90:614-21. (Pubitemid 29332919)
34. Milner JA. A historical perspective on garlic and cancer. J Nutr 2001; 131:1027-31.
35. Schaffer EM, Liu JZ, Green J, Dangler CA, Milner JA. Garlic and associated allyl sulfur components inhibit N-methyl-N-nitrosourea induced rat mammary carcinogenesis. Cancer Lett 1996; 102:199-204.
36. Reed JC. Dysregulation of apoptosis in cancer. J Clin Oncol 1999; 17:2941-53. (Pubitemid 29415256)
37. Fisher DE. Apoptosis in cancer therapy: crossing the threshold. Cell 1994; 78:539-42. (Pubitemid 24268576)
38. Lowe SW, Ruley HE, Jacks T, Houseman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993; 74:957-67. (Pubitemid 23289454)
39. Tenzer A, Pruschy M. Potentiation of DNA-damage-induced cytotoxicity by G2 checkpoint abrogators. Curr Med Chem Anti-Canc Agents 2003; 3:35-6.
40. Yu Q, La Rose J, Zhang H, Takemura H, Kohn KW, Pommier Y. UCN-01 inhibits p53 upregulation and abrogates gamma-radiation-induced G(2)-M checkpoint independently of p53 by targeting both of the checkpoint kinase Chk2 and Chk1. Cancer Res 2002; 62:5743-8. (Pubitemid 35204730)
41. Elledge SJ. Cell cycle checkpoints: preventing an identity crisis. Science 1996; 274:1664-72. (Pubitemid 26414889)
42. Maity A, McKenna WG, Muschel RJ. The molecular basis for cell cycle delays following ionizing radiation: a review. Radiother Oncol 1994; 31:1-4.
43. Xiao D, Choi S, Johnson DE. Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2. Oncogene 2004; 23:5594-606. (Pubitemid 39093037)
44. Xiao D, Herman-Antosiewicz A, Antosiewicz J, Xiao H, Brisson M, Lazo JS, et al. Diallyl trisulfide-induced G2-M phase cell cycle arrest in human prostate cancer cells is caused by reactive oxygen species-dependent destruction and hyperphosphorylation of Cdc25C. Oncogene 2005; 24:6256-68. (Pubitemid 43080049)
45. Nobury C, Nurse P. Animal cell cycles and their control. Trends Biochem Sci 1992; 19:143-5.
46. Xiao D, Zeng Y, Hahm ER, Kim YA, Ramalingam S, Singh SV. Diallyl trisulfide selectively causes Bax- and Bak-mediated apoptosis in human lung cancer cells. Environ Mol Mutagen 2009; 50:201:12.
47. Herman-Antosiewicz A, Singh SV. Checkpoint kinase 1 regulates diallyl trisulfide-induced mitotic arrest in human prostate cancer cells. J Biol Chem 2005; 280:28519-28. (Pubitemid 41105752)
48. Hartwell LH, Kastan MB. Cell cycle control and cancer. Science 1994; 266:1821-8.
49. Yuan J, Yan R, Krämer A, Eckerdt F, Roller M, Kaufmann M, et al. Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells. Oncogene 2004; 23:5843-52. (Pubitemid 39093030)
50. Xie XH, An HJ, Kang S, Hong S, Choi YP, Kim YT, et al. Loss of Cyclin B1 followed by downregulation of cyclin A/Cdk2, apoptosis and antiproliferation in HeLa cell line. Int J Cancer 2005; 116:520-5. (Pubitemid 41099187)
51. Yuan J, Krämer A, Matthess Y, Yan R, Spänkuch B, Gätje R, et al. Stable gene silencing of cyclin B1 in tumor cells increases susceptibility to taxol and leads to growth arrest in vivo. Oncogene 2006; 25:1753-62.
52. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991; 253:49-53. (Pubitemid 21917115)
53. Lee JM, Bernstein A. Apoptosis, cancer and the p53 tumour suppressor gene. Cancer Metastasis Rev 1995; 14:149-61.
54. Liebermann DA, Hoffman B, Steinman RA. Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways. Oncogene 1995; 11:199-210.
55. Chiarugi V, Magnelli L, Cinelli M, Basi G. Apoptosis and the cell cycle. Cell Mol Biol Res 1994; 40:603-12.
56. Vogelstein B, Kinzler KW. p53 function and dysfunction. Cell 1992; 70:523-6.
57. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75:817-25. (Pubitemid 23346378)
58. Harper J, Adami W, Guy R. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993; 75:805-16. (Pubitemid 23346377)
59. Xiao D, Shivendra VS. Diallyl trisulfide, a constituent of processed garlic, inactivates Akt to trigger mitochondrial translocation of BAD and caspase-mediated apoptosis in human prostate cancer cells. Carcinogenesis 2006; 27:533-40. (Pubitemid 43372883)
60. Gajja S, Hugh JM, Verwijs J. The Bax-alpha: Bc1-2 ratio modulates the response to dexamethasone in leukaemic cells and is highly variable in childhood acute leukaemia. Int J Cancer 1997; 71:959-65.
61. Zhou M, Gu L, Yeager AM, Findley HW. Expression and regulation of Bcl-2, Bcl-xl and Bax correlate with p53 status and sensitivity to apoptosis in childhood acute lymphoblastic leukemia. Blood 1997; 89:2986-93. (Pubitemid 27172586)
62. Kane DJ, Ord T, Anton R, Bredesen DE. Expression of bcl-2 inhibits necrotic neural cell death. J Neurosci Res 1995; 40:269-75.
63. Testa JR, Bellacosa A. AKT plays a central role in tumorigenesis. Proc Nat Acad Sci USA 2001; 98:10983-5. (Pubitemid 32928669)
64. Tashiro E, Tsuchiya A. Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression. Cancer Sci 2007; 98:629-35. (Pubitemid 46563437)
65. Blagosklonny MV, Schulte T, Nguyen P, Trepel J, Neckers LM. Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. Cancer Res 1996; 56:1851-4.
66. Haldar S, Chintapalli J, Croce CM. Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res 1996; 56:1253-5. (Pubitemid 26080965)
67. Dulic V, Stein GH, Farahi Far D, Reed SI. Nuclear accumulation of p21Cip1 at the onset of mitosis: a role at the G2/M-phase transition. Mol Cell Biol 1998;18:546-57. (Pubitemid 28021065)
68. Hiyama H, Iavarone A, LaBaer J, Reeves SA. Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression. Oncogene 1997; 14:2533-42. (Pubitemid 27273515)
69. Blagosklonny MV, El-Deiry WS. Acute overexpression of wt p53 facilitates anticancer drug-induced death of cancer and normal cells. Int J Cancer 1998; 75:933-40. (Pubitemid 28134120)
70. Herman-Antosiewicz A, Powolny AA, Singh SV. Molecular targets of cancer chemoprevention by garlic-derived organosulfides. Acta Pharmacol Sin 2007; 28:1355-64. (Pubitemid 47366679)
71. Xiao D, Choi S, Johnson DE, Vogel VG, Johnson CS, Trump DL, et al. Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2. Oncogene 2004; 23:5594-606. (Pubitemid 39093037)
72. Kim YA, Xiao D, Xiao H, Powolny AA, Lew KL, Reilly ML, et al. Mitochondria-mediated apoptosis by diallyl trisulfide in human prostate cancer cells is associated with generation of reactive oxygen species and regulated by Bax/Bak. Mol Cancer Ther 2007; 6:1599-609. (Pubitemid 46954027)